Galderma Group AG (GALD) Stock Price & News

GALD:SWX

Galderma Group AG

CHF 173.70

-1.33%

(-2.35) 1D

Oct 19, 5:31:13 PM GMT+2 · CHF

All symbols

	Symbol	Price	Change	% Change

Next call in 3 days

Thu, Oct 22, 3:30 PM

Fiscal period

Q3 2026

- / -

Revenue / Est. (USD)

- / 1.55B

Fiscal Q3 2026 earnings call

Waiting for the earnings call

At a glance: upcoming earnings

Insights from the latest news and reports

Previous reportsAll values in USD

Loading Previous Earnings...

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	1.39B	1.39B	1.57B	1.57B
Cost of goods sold	438.00M	438.00M	469.00M	469.00M
Cost of revenue	438.00M	438.00M	469.00M	469.00M
Research and development expenses	70.50M	70.50M	68.50M	68.50M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	640.50M	640.50M	717.50M	717.50M
Operating expense	702.50M	702.50M	786.50M	786.50M
Total operating expenses	1.14B	1.14B	1.26B	1.26B
Operating income	247.00M	247.00M	318.50M	318.50M
Other non operating income	-5.50M	-5.50M	-8.50M	-8.50M
EBT including unusual items	193.50M	193.50M	277.00M	277.00M
EBT excluding unusual items	204.00M	204.00M	285.00M	285.00M
Income tax expense	-16.00M	-16.00M	55.00M	55.00M
Effective tax rate	-8.27%	-8.27%	19.86%	19.86%
Other operating expenses	-8.50M	-8.50M	500.00K	500.00K
Net income	209.50M	209.50M	222.00M	222.00M
Net profit margin	15.10%	15.10%	14.10%	14.10%
Earnings per share	-	-	-	-
Interest and investment income	3.50M	3.50M	5.00M	5.00M
Interest expense	-38.50M	-38.50M	-38.50M	-38.50M
Net interest expenses	-35.00M	-35.00M	-33.50M	-33.50M
Depreciation and amortization charges	-	-	-	-
EBITDA	301.50M	301.50M	400.50M	400.50M
Gain or loss from assets sale	-	-	-	-

Finance